Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Bisacodyl stimulant laxative - Medication Information

Product NDC Code 68163-116
Drug Name

Bisacodyl stimulant laxative

Type Brand
Pharm Class Increased Large Intestinal Motility [PE],
Stimulant Laxative [EPC],
Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Active Ingredients
Bisacodyl 5 mg/1
Route ORAL
Dosage Form TABLET, COATED
RxCUI drug identifier 308753
Application Number part334
Labeler Name Raritan Pharmaceuticals Inc
Packages
Package NDC Code Description
68163-116-25 1 blister pack in 1 carton (68163-116-25) / 25 tablet, coated in 1 blister pack
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
Active ingredient (in each tablet) Bisacodyl, USP 5 mg

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Directions take with a glass of water adults and children 12 years of age and over 1 to 3 tablets in a single daily dose children 6 to under 12 years of age 1 tablet in a single daily dose children under 6 years of age ask a doctor
adults and children 12 years of age and over 1 to 3 tablets in a single daily dose
children 6 to under 12 years of age1 tablet in a single daily dose
children under 6 years of ageask a doctor

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
Inactive ingredients acacia, anhydrous calcium sulfate, anhydrous lactose, carnauba wax, colloidal silicon dioxide, corn starch, D&C yellow No. 10, FD&C yellow No. 6, gelatin, iron oxide, iron oxide black, iron oxide yellow, magnesium stearate, microcrystalline cellulose, polyethylene glycol (PEG) 400, polyvinyl acetate phthalate, povidone, shellac, sodium starch glycolate, stearic acid, sugar, talc, titanium dioxide.

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Use ▪ for relief of occasional constipation and irregularity ▪ this product generally produces a bowel movement in 6 to 12 hours

Purpose

Information about the drug product’s indications for use.
Purpose Stimulant laxative

Spl product data elements

Usually a list of ingredients in a drug product.
Bisacodyl Stimulant Laxative Bisacodyl BISACODYL DEACETYLBISACODYL ACACIA CALCIUM SULFATE ANHYDROUS ANHYDROUS LACTOSE CARNAUBA WAX SILICON DIOXIDE STARCH, CORN D&C YELLOW NO. 10 FD&C YELLOW NO. 6 GELATIN, UNSPECIFIED FERROSOFERRIC OXIDE FERRIC OXIDE RED FERRIC OXIDE YELLOW MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 400 Polyvinyl Acetate Phthalate POVIDONE, UNSPECIFIED SHELLAC SODIUM STARCH GLYCOLATE TYPE A POTATO STEARIC ACID RAW SUGAR TALC TITANIUM DIOXIDE RP116

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
Principal Display Panel NDC# 68163-116-25 *Compare to the Active Ingredient in Dulcolax® Tablets Bisacodyl Laxative Bisacodyl, USP 5 mg/Stimulant Laxative Gentle, Overnight relief constipation relief 25 Coated Tablets *This product is not manufactured or distributed by Chattem Inc., the owner of the registered trademark Dulcolax® Tablets. TAMPER EVIDENT: Do not use if any individual unit is broken or open. IMPORTANT: Keep this carton for future reference on full labeling. Manufactured by: Raritan Pharmaceuticals 8 Joanna Court, East Brunswick, NJ 08816 DRx Choice Bisacodyl Laxative
IMPORTANT: Keep this carton for future reference on full labeling.

Spl unclassified section

Information not classified as belonging to one of the other fields. Approximately 40% of labeling with effective_time between June 2009 and August 2014 have information in this field.
Other information • store at room temperature • Protect from excessive humidity

Ask doctor

Information about when a doctor should be consulted about existing conditions or sumptoms before using the drug product, including all warnings for persons with certain preexisting conditions (excluding pregnancy) and all warnings for persons experiencing certain symptoms. The warnings under this heading are those intended only for situations in which consumers should not use the product until a doctor is consulted.
Ask a doctor before use if you have ▪ stomach pain, nausea or vomiting ▪ a sudden change in bowel habits that lasts more than 2 weeks

Do not use

Information about all contraindications for use. These contraindications are absolute and are intended for situations in which consumers should not use the product unless a prior diagnosis has been established by a doctor or for situations in which certain consumers should not use the product under any circumstances regardless of whether a doctor or health professional is consulted.
Do not use if you cannot swallow without chewing.

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at (1-800-222-1222).

Questions

A telephone number of a source to answer questions about a drug product. Sometimes available days and times are also noted.
Questions or comments? 1-866-467-2748

Stop use

Information about when use of the drug product should be discontinued immediately and a doctor consulted. Includes information about any signs of toxicity or other reactions that would necessitate immediately discontinuing use of the product.
Stop use and ask a doctor if ▪ you have rectal bleeding or fail to have bowl movement after using this product. These could be signs of a serious condition. ▪ you need to use a laxative for more than 1 week

When using

Information about side effects that people may experience, and the substances (e.g. alcohol) or activities (e.g. operating machinery, driving a car) to avoid while using the drug product.
When using this product ▪ it may cause stomach discomfort, faintness and cramps ▪ do not chew or crush tablet(s) ▪ do not use within 1 hour after taking an antacid or milk

Pregnancy or breast feeding

Pregnancy or Breast feeding
If pregnancy or breast-feeding, ask a health professional before use.

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Warnings Do not use if you cannot swallow without chewing. Ask a doctor before use if you have ▪ stomach pain, nausea or vomiting ▪ a sudden change in bowel habits that lasts more than 2 weeks When using this product ▪ it may cause stomach discomfort, faintness and cramps ▪ do not chew or crush tablet(s) ▪ do not use within 1 hour after taking an antacid or milk Stop use and ask a doctor if ▪ you have rectal bleeding or fail to have bowl movement after using this product. These could be signs of a serious condition. ▪ you need to use a laxative for more than 1 week If pregnancy or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at (1-800-222-1222).

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API